ACC Action Center
Welcome to the ACC Action Center, bringing you the latest updates from the American College of Cardiology’s Annual Scientific Session & Expo, hosted in partnership with the World Congress of Cardiology. This collection will highlight emerging clinical data and explore the latest practice-changing advances in the field of cardiology.
Episodes 31-45 of 47
Social Media & Heart Health: Insights from ACC.23
ACC Action CenterSocial Media & Heart Health: Insights from ACC.23
Exploring Clinical Data From Day 1 of ACC.23
ACC Action CenterExploring Clinical Data From Day 1 of ACC.23
Developments in Cardiology from Day 2 of ACC.23
ACC Action CenterDevelopments in Cardiology from Day 2 of ACC.23
Anticipated Updates on Statin Intolerance at ACC 2023
ACC Action CenterAnticipated Updates on Statin Intolerance at ACC 2023
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
ACC Action CenterA First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
- advertisement
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
ACC Action CenterReductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
Novel Form of CV Research with Dietary Education in the Grocery Store
ACC Action CenterNovel Form of CV Research with Dietary Education in the Grocery Store
Beginning of an Era: Treatment of Elevated Lp(a)
ACC Action CenterBeginning of an Era: Treatment of Elevated Lp(a)
PCSK9i Reduces Plaque Burden in Coronary Arteries
ACC Action CenterPCSK9i Reduces Plaque Burden in Coronary Arteries
Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
ACC Action CenterStudy with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
ACC Action CenterReduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
- advertisement
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
ACC Action CenterCardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
Impact of New First-in-Class Medical Therapy in Obstructive HCM
ACC Action CenterImpact of New First-in-Class Medical Therapy in Obstructive HCM
Treatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
ACC Action CenterTreatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
